Navigation Links
Oncolytics Biotech Inc. Announces Clinical Update Conference Call
Date:11/3/2008

. Forward-looking statements, including the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN(R) as a cancer treatment, the tolerability of REOLYSIN(R) outside a controlled test, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN(R), uncertainties related to the research and development of pharmaceuticals and uncertainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements.


'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Collaborators Present Positive Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting
2. Oncolytics Biotech Inc. Collaborators Present Positive Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting
3. Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting
4. Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting
5. Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium
6. Oncolytics Biotech Inc. Collaborators to Present Preclinical Combination REOLYSIN(R) and Cisplatin Research at EORTC-NCI-AACR Annual Meeting
7. Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2008
8. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
9. Oncolytics Biotech Inc. Completes Initial Scale Up of Manufacturing Process for REOLYSIN(R) to Commercial Scale
10. Media Advisory - Oncolytics Biotech Inc. to Present at Maxim Group Growth Conference
11. Oncolytics Biotech Inc. Announces Issuance of 28th U.S. Patent

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... LYNBROOK, N.Y., Nov. 6 ...a biopharmaceutical company developing first-in-cl...s financial results for the third quarter ended Se...that, in September of this year, the FDA,s Arthrit...a vote of 12-0, the approval of XIAFLEX(TM) for th...
(Date:11/6/2009)... VIENNA, Austria, November 6 E...ng, manufacturing, and marketing enzymes for the,c...ed into a research,agreement with Bio Sidus, the l... , The agreement gives EUCODIS Bioscience...nterest - to Bio Sidus, proprietary collection of,...
(Date:11/6/2009)... CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolyti...s" or the "Company") today announced updated resul...) in patients with sarcomas metastatic to the lung...ctive Tissue Oncology Society Meeting held in Miam...ster presentation, entitled "A Phase II Study of I...
(Date:11/5/2009)...TRANSPORTATION -- Gone hybrid . . . , Fuel eco...es are now posted at the www.fueleconomy.gov web...ed and maintains for the U.S. Department of Energy...e of the top 10 vehicles on the best fuel economy ... (51 MPG city; 48 highway). "This list proves that...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
...tix, Inc.,(Nasdaq: GXDX ), a specialized laborato...s participation at the UBS Global Life Sciences Co...t in New York City on September 22,- 25, 2008., D...Genoptix, will,present at the conference on Monday... EDT. Mr. Schuling will provide an overview of the...
... palm plantations will worsen the dual environment... unless rainforests are better protected, warn sci...bject to date. , Lead author, Emily Fitzherbert f...y of East Anglia said: "There has been much debate...deforestation and its impacts on biodiversity. We ...
...uter processors will likely be the move from today...uits, and the first three-dimensional synchronizat...he University of Rochester., Unlike past attempts ...umber of regular processors stacked on top of one ... optimize all key processing functions vertically,...
Other Biology Technology:Genoptix Announces Participation at the UBS Global Life Sciences Conference 2Oil palm plantations are no substitute for tropical rainforests, a new study shows 2Oil palm plantations are no substitute for tropical rainforests, a new study shows 3First 3-D processor runs at 1.4 Ghz on new architecture 2
(Date:11/4/2009)...ce) , United States Using Less Water Today ,...did 35 years ago, despite a 30 percent population ...table to alternative cooling methods at power plan...g to the latest USGS water use report, nearly half...oling thermoelectric power plants. Irrigation acco...
(Date:11/4/2009)...urns out, hold the power to help militaries and mu...n up toxic waste on test sites. , Compounds know...ack in World War II and have been used in military...ds are often used to propel tank shells and act li...increased knowledge of their environmentally harmf...
(Date:11/4/2009)... Spectros, developer and manufactur...es which shed light on life-threatening diseases, ...ibution deals for both its T-Stat® VLS Tissue...e Australia, New Zealand, The Netherlands, Belgiu...Spain, Portugal, Poland, Greece, Turkey, and Russi...
Breaking Biology News(10 mins):USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Genomic research will enable greener cleanup of military explosive test sites 2Spectros Signs New International Distribution Deals 2Leading American Healthcare Experts Press Congress to Act Quickly on Health Reform 57511 1Leading American Healthcare Experts Press Congress to Act Quickly on Health Reform 57511 2Leading American Healthcare Experts Press Congress to Act Quickly on Health Reform 57511 3Leading American Healthcare Experts Press Congress to Act Quickly on Health Reform 57511 4Eclipse Introduces Smooth Cool HR SR with Unique Chilling Technology 57507 1Eclipse Introduces Smooth Cool HR SR with Unique Chilling Technology 57507 2Solos Endoscopy Inc Receives Purchase Order from the National Cancer Institute 57504 1Solos Endoscopy Inc Receives Purchase Order from the National Cancer Institute 57504 2
...n already for its role in schizophrenia has been ... a report in todays advance on-line issue of Natur...Medical Center (BIDMC), the study further suggests...a diagnostic marker and therapeutic supplement for...r. , Characterized by hypertension, proteinuria, ...
...ts using a lotion which glows under ultraviolet li...ts are not properly cleaned. Their findings, publi...seases, also show that spores from the nasty bacte... the loo even when it has been thoroughly wiped do... Manitoba, Canada investigated the spread of so-ca...
...d migration to EAC ePassport technology, DALLAS, ...st, Inc. (Nasdaq: ENTU ) will provide its proven ...ent to help authenticate sensitive,biometric infor... (MRTDs),-- also known as ePassports -- which will... end of 2008., "The need to securely identify peo...
Other Biology News:A new gene trigger for pregnancy disorder identified 2UV lotion lights the way to cleaner facilities 2Entrust, Hewlett Packard Partner to Deploy Taiwanese ePassports, Authenticate Biometric Data 2Entrust, Hewlett Packard Partner to Deploy Taiwanese ePassports, Authenticate Biometric Data 3
Dithiothreitol, 1M from Upstate
BD IMag Anti-Mouse CD90.2 (Thy1.2) Particles-DM 2 x 109 cells from BD Biosciences Pharmingen
Acetyl-Histone H3 Immunoprecipitation (ChIP) Assay Kit from Upstate
pRSET-E Echo Expression Vector Kit from Invitrogen
Biology Products: